Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
GSK to seek FDA approval for Jemperli in high-profile cancer use
Jemperli’s potential in the small rectal cancer indication drew public attention in 2022 with a 100% complete response rate from a small study.
Angus Liu
Jul 13, 2026 10:50am
Germany approves controversial healthcare reform package
Jul 13, 2026 10:40am
Decision readiness is the next AI advantage
Brought to you by
The Directions Group
The Oral GLP-1 Tracker: Lilly’s Foundayo launch remains ‘muted’
Jul 10, 2026 2:30pm
9 of the Top 10 Pharma Manufacturers Choose Redi Health
Brought to you by
Redi Health
FDA expands Padcev-Keytruda combo to more MIBC patients
Jul 10, 2026 1:10pm
